Shop
Body Art News

What Is BioFlex® Jewelry Made Of? The Creator Explains

PP

Chief Engineer

Patrick Poli

Journal Date

2026-04-06

Last Reviewed

2026-10-30

The Correction From the Source

A few weeks ago, I read an AI-generated article that described BioFlex® as a "polyether urethane" and Bioplast as "TPU (thermoplastic urethane)." Apparently, I've been manufacturing a urethane-based polymer for 25 years and nobody thought to tell me. The same article informed me that BioFlex® should only be worn for 6–12 weeks before being swapped out for titanium, news that will surprise the tens of thousands of people who have been wearing it comfortably and safely for years, some for over a decade.

I refused to publish that article. What I'm writing instead is the correction it deserved.

I created BioFlex® at Europierce Worldwide Ltd in the UK more than 25 years ago. I spent over a year developing the material, running injection trials, making molds, testing formulations, before I was satisfied it was right. Since then, I've watched this industry evolve, seen regulations tighten, watched cheap copies flood the market, and witnessed the growing confusion between what BioFlex® actually is and what people assume it must be. It's time to set the record straight.

Key Takeaways:
» BioFlex® is not acrylic, not TPU, not PMMA, not nylon, and not PVC. It is a medical-grade random copolymer (PP-R class). So is Bioplast. Neither has anything to do with thermoplastic urethane.
» BioFlex® was certified as passing the ISO 10993 biological tests and built on a USP Class VI biocompatible resin before regulators required it. It is not a material scrambling to meet new rules, it was ahead of them.
» The "68% adverse event" statistic cited in recent studies almost certainly refers to cheap uncertified Asian copies, not genuine BioFlex® or Bioplast. Lumping them together is the equivalent of blaming Rolex for injuries caused by counterfeit watches.
» BioFlex® phthalate traces measure below 1 ppm (0.0001%), three orders of magnitude below the REACH SVHC 0.1% threshold. No PVC, no plasticizers, no brominated flame retardants.
» The emerging regulation mandating "temporary post-operative use only" labelling is a step backwards, because it was written around TPU properties and then applied broadly to all flexible polymers, without distinguishing certified medical-grade materials from cheap imports.

1. The Identity Crisis: What BioFlex® Actually Is

Let's start with chemistry, because the confusion here is foundational.

You will find websites, some of them otherwise reputable, describing BioFlex® as acrylic, as PMMA, as TPU, or as "a type of flexible plastic." One piercing retailer even lists BioFlex® as "a type of acrylic." This is wrong. Acrylic (PMMA) is not a safe body jewelry material at all, it is porous, non-autoclavable, and unsuitable for pierced tissue. BioFlex® is categorically not acrylic.

The most common technical misidentification is TPU: thermoplastic urethane.

BioFlex® vs. Common Misidentifications

It sounds plausible, "flexible polymer for medical use", and TPU is used in some flexible body jewelry, typically the cheaper, uncertified kind. But BioFlex® and Bioplast are both manufactured from advanced random copolymers in the PP-R class, a completely different polymer family, produced by some of the largest and most reputable medical-grade polymer manufacturers in the world. The chemistry, the regulatory profile, and the safety data are entirely different.

Why does this confusion persist? Partly because we have deliberately not published the exact formulation. That is a trade secret, and a necessary one. If I released the precise specification of BioFlex®, I would be handing every factory in Shenzhen the blueprint to copy it exactly. That is not going to happen. I spent more than a year developing this material. It was developed with the benefit of the end user in mind. Protecting it protects the consumer.

What I will tell you is what it is not: it is not urethane-based, it does not release urethane monomers, and it has none of the toxicological profile that TPU carries. The AI article claimed BioFlex® releases 0.3–0.8% urethane monomers. That figure applies to TPU. BioFlex® phthalate traces from the catalyst measure below 1 ppm (0.0001%). The REACH Article 33 SVHC threshold triggers at 0.1% (1,000 ppm). We are three orders of magnitude below it. There is no PVC. There are no plasticizers. There are no brominated flame retardants.

That is not a reformulation to meet new regulations. That has always been the compliance profile of BioFlex®. For the current state of material certification standards, the baseline BioFlex® was designed to exceeds remains relevant today.

2. The Counterfeit Problem: When "BioFlex" Isn't BioFlex®

Here is the most important thing I can tell any piercing professional reading this: the market is full of products labelled "bioflex" or "bioplast" that are nothing of the sort.

I trademarked BioFlex® precisely because I saw this coming. My friend Robert Redl, who owns Steel and Silver in Thailand, commercialised Bioplast genuinely two to three years after BioFlex® launched. Both of us were working with certified, tested, properly manufactured material from the same class of medical-grade polymers. If you are looking for genuine Bioplast, Robert is the person to talk to, Steel and Silver is one of the finest sources of quality body jewelry in the world. Between us, we represent the only two authentic sources for these materials. Then the copies arrived.

When I read about a 2024 meta-analysis attributing 68% of flexible polymer complications to extended post-operative wear, my first question is: which materials were actually studied? Because if researchers cannot distinguish between genuine BioFlex®, genuine Bioplast, and cheap uncertified copies sold under the same names, and most cannot, then the conclusions are meaningless. You cannot apply adverse event data from uncertified random-copolymer knockoffs to a certified, ISO-tested product and draw any valid conclusions. You are not studying the same material.

Various sources describe BioFlex® correctly as a premium flexible body jewelry material. But Reddit threads and general consumer resources routinely conflate all flexible polymer jewelry into a single category, and many piercing studios stock whatever comes cheapest from an import catalogue, labelled in English with a brand name that sounds like ours.

The experienced piercers, the ones I respect and work with, know the difference. They ask for certification. They recognise that genuine BioFlex® and genuine Bioplast come with documentation. They understand that the price difference exists for a reason. These are the professionals keeping their clients safe.

For everyone else: if your supplier cannot produce certification documentation in 48 hours, do not stock their products. I can provide an official SVHC-free declaration to any professional who requests it, this is the correct legal instrument, not a vague "compliance letter." Under REACH Article 33, disclosure is only obligatory when a substance of very high concern exceeds 0.1% in the article. For genuine BioFlex®, that obligation does not arise, because nothing exceeds that threshold. Our SVHC-free declaration and compliance documentation is available to any trade professional.

3. Regulation Reality Check: When the Rules Miss the Target

I have a complicated relationship with regulation.

I was developing BioFlex® at a time when piercing was essentially unregulated. Government bodies had no idea what piercers were doing, what materials they were using, or what standards should apply. I remember helping Bournemouth Borough Council write their piercing regulations from scratch, because they didn't have a clue, and someone had to. That someone was me.

So when I say I support proper regulation, I mean it. I was getting BioFlex® certified as passing the ISO 10993 biological tests and built on a USP Class VI biocompatible resin before anyone required it. I did that because it was the right thing to do, not because a regulator told me to.

But here is where I have a genuine grievance with the current regulatory direction: the new rules are being written around TPU chemistry and then applied to all flexible polymers. This is the regulatory equivalent of writing food safety rules around spoiled milk and then applying them to fine wine because both are liquids.

PTFE has its own history to consider here. DuPont's Teflon was an excellent material in medical applications for years, inert, flexible, biocompatible. Then it was used in load-bearing joints, where it degraded under mechanical stress and caused serious harm. The resulting litigation was enormous, and DuPont now disclaims all medical use of PTFE in their product documentation. PTFE is still used medically today, carefully and appropriately, but the cautionary history lingers. The lesson was not "all polymers are dangerous." The lesson was "understand your material's specific limitations."

The current regulatory narrative draws the wrong lesson. It treats BioFlex®, a material with 25 years of clean real-world performance and complete ISO and REACH compliance, as if it shares the risk profile of uncertified TPU imports. It mandates "temporary post-operative use only" labelling for materials that have a 25-year track record of indefinite safe wear. That is not consumer protection. That is consumer misinformation, imposed through well-intentioned ignorance.

The REACH regulatory framework is a sound structure for managing genuine chemical hazards. I have no argument with its principles. My argument is with its application when regulators lack the technical granularity to distinguish between certified medical-grade random copolymers and cheap TPU knockoffs. The solution is better information, not broader restriction.

The Gatekeepers Who Never Called

And then there is the APP, the Association of Professional Piercers, based in the United States. The APP positions itself as the authority on piercing standards. Their approved materials list for initial piercings includes ASTM F136 titanium, ASTM F138 surgical steel, solid 14k+ gold, niobium, platinum, and glass. You will notice something missing. BioFlex® is not on that list. Bioplast is not on that list. Neither material has ever been formally evaluated by the APP, because in 25 years, they have never contacted me to discuss BioFlex®, and to my knowledge, they have never contacted Robert about Bioplast either.

Twenty-five years. Not one email. Not one phone call. Not one invitation to present, discuss, or submit documentation. And this from an organisation that claims to set the standard for piercing safety.

I tried going through other channels. Years ago, I attempted to update the Wikipedia page on body jewelry materials with accurate information about BioFlex®. The edits were removed within two weeks, every time. Wikipedia is a collaborative platform, but certain pages are watched by communities with established positions, and the piercing materials page reflects the APP's metal-centric worldview.

To understand why, you need to understand the APP's origins. It was founded by, and its membership largely consists of, professionals and manufacturers in the metal body jewelry industry. Their mandate around internally threaded jewelry is a useful case study. The APP's guidelines require all threaded jewelry 14 gauge and larger to be internally threaded, citing safety as the reason. The logic sounds reasonable: external threads can scratch the piercing channel during insertion. But here is what nobody seems to question: an internally threaded barbell or labret has a hollow shaft. When worn in a piercing, body fluids migrate into that hollow channel. When the client screws on the attachment end, those fluids are sealed inside, creating an environment that is difficult to clean and potentially hospitable to bacteria. An externally threaded bar, by contrast, has a solid shaft, the thread is exposed at the end, where it can be cleaned before an attachment is applied. Both designs have trade-offs. But the APP presented one as the only acceptable standard, and the industry followed without asking the obvious question.

I am not suggesting the APP acts in bad faith. I am suggesting they operate within a framework that was built by and for metal jewelry manufacturers. Flexible polymer materials, the ones that protect tooth enamel, prevent gum recession, and act as shock absorbers, represent a category that does not benefit their core membership commercially. When your standard-setting body has a structural interest in one material family, the absence of curiosity about another is not surprising. It is predictable.

The consequence is an information vacuum. Piercers who follow the APP as gospel are never introduced to BioFlex® or Bioplast through official channels. The materials don't appear in APP training materials. They don't appear on the approved list. And when someone tries to add them to Wikipedia, the edits don't survive. Getting accurate information out there is not always easy, and this is a significant part of why the confusion persists.

4. Twenty-Five Years of Real-World Evidence

Let me tell you what I actually observe, after a quarter century in this business.

People switch from metal to BioFlex® and do not come back. Not because I tell them to stay, because they experience the difference. A flexible oral piercing touching the enamel of your teeth or the soft tissue of your gums is simply less destructive than metal. That is not a marketing claim; it is physics. Flexibility absorbs shock. Rigid metal concentrates it.

I have seen people sleep comfortably on ear piercings that were previously impossible to sleep on. I have seen cartilage piercings heal with less disruption because the jewelry moved with the body rather than against it. I have seen navel piercings survive incidents, a child kicking, a bag catching, that would have torn a metal ring clean through. BioFlex® acts as a shock absorber. That matters for real bodies living real lives.

The zero-nickel profile matters too, particularly as nickel sensitisation becomes more prevalent. A significant percentage of the population develops contact sensitivity to nickel, and conventional body jewelry, even surgical steel, contains trace nickel. BioFlex® contains none. For clients with existing sensitivities, this is not optional: it is the difference between a successful piercing and a chronic allergic reaction.

On the antimicrobial side: in 2008, I worked with the University of Dijon on a silver-ion antimicrobial that we developed as an additive, not a coating. This distinction matters enormously. Antimicrobial coatings on polymers degrade with autoclaving and wear, which is why critics correctly dismiss them as ineffective. But an antimicrobial additive mixed homogeneously into the material during injection moulding distributes the silver ions throughout the entire piece. You cannot autoclave away what is embedded in the polymer matrix. From my direct observation over the years, clients using the antimicrobial version of BioFlex® resolve redness and irritation noticeably faster. I acknowledge this is not peer-reviewed clinical data, that study has not been funded. But the mechanism is sound, and the anecdotal evidence across thousands of clients is consistent.

What I have not seen, in 25 years, is a material-related adverse event with genuine BioFlex® or genuine Bioplast. I have seen piercings go wrong because of misuse, accidents, anatomy, and technique. I have not seen them go wrong because of the material itself. That is a meaningful data point, even if it is not a randomised controlled trial. See our full innovation timeline for the development history behind these claims.

5. What Piercers and Consumers Should Actually Do

The practical guidance here is simpler than the regulatory complexity suggests:

Verify your source. Genuine BioFlex® and Bioplast come from known, certifiable manufacturers. Ask for documentation. A REACH Article 33 SVHC-free declaration is the legally correct document, not a vague letter saying "we comply with regulations." If a supplier cannot produce specific compliance documentation, that is your answer. Download our SVHC-free declaration and compliance datasheet here.

Understand the material you are using. There is no single category called "flexible polymer jewelry." Certified medical-grade random copolymers, TPU, PTFE, acrylic, and silicone all have different chemical profiles, different regulatory statuses, and different clinical suitabilities. Your supplier should be able to tell you exactly what you are stocking.

Do not limit genuine BioFlex® to the post-operative window if your client is happy in it. The "6–12 weeks then switch to titanium" protocol was never based on BioFlex® performance data. It was based on TPU limitations, applied without distinction. A client who has been wearing BioFlex® comfortably for two years and wants to continue is not doing anything wrong. The material is not degrading, it is not releasing toxins, and there is no clinical basis for forcing a transition. If they want to switch to titanium, that is a perfectly good option. It should not be presented as a legal obligation.

For oral piercings, the case for BioFlex® is particularly strong. Less enamel wear, less gum recession, more flexibility for sleeping and eating. This is not a marginal advantage. Dentists charge considerably more than a BioFlex® bar costs. The maths is not complicated.

Distinguish between regulation and truth. The new labelling requirements are a regulatory fact. I am not advising anyone to ignore them. But understanding that the science behind those labels does not reflect the actual safety profile of genuinely certified materials is also important. Know what you are using. Know why it is safe. Be able to explain it to your clients.

6. Body Art Is Not a Regulatory Problem to Be Solved

Body modification has existed for thousands of years. Across every culture and era, humans have chosen to mark, adorn, and transform their bodies as an expression of identity, community, and beauty. The millennial generation, and every generation since, did not invent this impulse. They inherited it, and they made it mainstream.

Good regulation of this art form should protect the people who practice and receive it. It should distinguish between dangerous materials and safe ones, between certified manufacturers and counterfeit operators, between evidence-based restrictions and precautionary overreach. It should be written by people who understand the materials they are regulating.

The current direction is imperfect on that last point. I say this not in anger but from experience, the same experience that led me to help a Borough Council write its own regulations from scratch because nobody else knew how. The appetite to regulate exists. The technical knowledge to regulate correctly does not always accompany it.

My invitation to regulators, industry bodies, and practitioners is the same: engage with the people who actually develop these materials. Ask questions. Distinguish between the cheap import and the certified original. The information exists. The expertise exists. Use it.

BioFlex® has 25 years of clean performance behind it. It was ahead of the regulations when it launched, and it remains compliant in full today. The label I object to is not a chemical warning. It is a category error, a consequence of writing rules about a material you have not properly identified.

The material is right. The label is wrong. That is the correction I am publishing.

---

Official Documentation

The compliance documents referenced throughout this article are now available for download. These are signed originals with company stamp, not marketing copy, not a terms-of-service letter.

📄 View SVHC-Free Declaration (PDF) ↗, Official declaration under REACH Article 33. Confirms no substance of very high concern exceeds 0.1% w/w in BioFlex® articles.

📄 View BioFlex® Compliance Data Sheet (PDF) ↗, Full compliance datasheet: material class, certifications, phthalate screening results (< 1 ppm), REACH status, and ISO 10993 references.

Both documents are available on the BioFlex® product page with View and Download buttons. Trade professionals, studio owners, and regulatory bodies are welcome to use these for their own compliance records.

---

Patrick Poli is the creator of BioFlex® body jewelry and Director of Poli International Co., Ltd (formerly Europierce Worldwide Ltd, UK). For certification documentation, SVHC-free declarations, or trade enquiries, contact us here.

7. FAQ: BioFlex® Material, Certification, and Common Misconceptions

Q: Is BioFlex® made from TPU (thermoplastic polyurethane)?
No. BioFlex® is manufactured from polypropylene random copolymer (PP-R), a semi-crystalline thermoplastic produced by co-polymerising propylene with ethylene. It is not a urethane, not an elastomer, and not related to thermoplastic polyurethane in any chemical, structural, or regulatory sense. TPU is a polyaddition product of diisocyanate and polyols, with a urethane linkage (-O-CO-NH-) in the backbone. PP-R has a carbon-carbon backbone with no nitrogen, no urethane groups, and no phthalate plasticizers. The confusion likely arises because both materials are flexible and used for body jewelry, but the chemistry, regulatory status, and biological response profiles are entirely different. If a supplier is selling you material they describe as "BioFlex" that is made of TPU, it is not genuine BioFlex®.

Q: What certifications does genuine BioFlex® carry and where can I verify them?
Genuine BioFlex® is certified as passing the ISO 10993 biological tests and is built on a resin certified to USP Class VI, the most rigorous USP plastics biocompatibility class. An SVHC-free declaration confirming no substance of very high concern exceeds 0.1% w/w under REACH Article 33 is available for download on this site. A full compliance datasheet confirming phthalate screening results below 1 ppm, material class, and ISO references is also available. These are signed originals with company stamp, not marketing materials. Any supplier claiming to sell "certified BioFlex®" should be able to provide equivalent documentation for their specific batch. If they cannot, the material may not be what is claimed.

Q: Why does the REACH labelling requirement flag BioFlex® if the material is certified safe?
The REACH labelling requirements introduced under EU Regulation 2022/1 on tattoo inks and permanent makeup apply to product categories, not individual certified materials. BioFlex® is captured under a broad category definition of "flexible polymer articles" that includes genuinely hazardous TPU and acrylic products. The regulation was written without sufficient technical differentiation between certified medical-grade random copolymers and commodity flexible plastics. The regulatory label is therefore a category classification error, not a material safety finding. Genuine BioFlex® fully complies with the underlying chemical restrictions in REACH, the issue is that the labelling framework was not written with enough specificity to distinguish it from lower-grade materials in the same broad category.

Q: Can BioFlex® be worn permanently, or should it be replaced with titanium after healing?
There is no clinical basis for mandatory replacement of BioFlex® with titanium after a defined healing period. The "switch to titanium after 6–12 weeks" protocol that circulates in the piercing community was developed in response to the known limitations of TPU, which can degrade, stiffen, and release oligomers over time. PP-R random copolymer does not have these degradation characteristics under physiological conditions. If a client is comfortable, healing well, and has no adverse reaction to BioFlex®, there is no material science justification for forcing a transition. Titanium is an excellent material and the choice to switch is entirely valid, but it should be presented as a preference option, not a safety requirement derived from BioFlex® performance data.

Q: Why has the APP never formally evaluated or endorsed BioFlex®?
The Association of Professional Piercers was founded primarily by and for professionals in the metal body jewelry industry. Its standards, including the internally-threaded jewelry requirements, reflect a framework developed around metal fabrication. Flexible polymer materials like BioFlex® represent a category that does not benefit the core metal-jewelry supply chain commercially. Despite 25 years of production history, ISO 10993 certification, and zero material-related adverse events observed in manufacture, BioFlex® has never been invited to present documentation to the APP or been included in their materials standards process. This is not necessarily bad faith, it reflects a structural bias in how the standard-setting body was constituted. Piercers who rely exclusively on APP-approved materials are working within a framework that has a documented gap in its coverage of certified flexible polymer materials.

Mind map · What Is BioFlex® Jewelry Made Of? The Creator Explains

  • BioFlex Jewelry Materials
    • PP-R Chemical Classification

      BioFlex is a medical-grade random copolymer in the PP-R class and is not thermoplastic polyurethane or acrylic.

      • Random Copolymer Structure
      • Not TPU Or Acrylic
    • Biocompatibility and Certifications

      BioFlex holds ISO 10993 biological evaluation certification and is manufactured from a USP Class VI certified biocompatible resin.

      • ISO 10993 Certification
      • USP Class VI Resin
    • Counterfeit Plastic Risks

      Uncertified counterfeit polymers sold as bioflex or bioplast are linked to high complication rates in piercing wearers.

      • Uncertified Cheap Imports
      • Required Supplier Verification
    • Mechanical And Physical Properties

      BioFlex possesses a flexural modulus of approximately 1200 MPa and can withstand 8 to 12 steam autoclave sterilization cycles.

      • High Flexural Modulus
      • Steam Autoclave Compatibility
StructureProcessMaterialHazard

4 branches, 0 sources. Each branch cites the article it came from; the labels beneath it are names, not claims.

BioFlex® Quiz

  1. 1. What is the true chemical classification of genuine BioFlex® and Bioplast jewelry?

    • ✓ Polypropylene random copolymer (PP-R class) — Genuine BioFlex® and Bioplast belong to the polypropylene random copolymer class, featuring a carbon-carbon backbone with no urethane groups.
    • • Thermoplastic polyurethane (TPU) — Thermoplastic polyurethane is a urethane-based polymer commonly used in cheaper, uncertified flexible jewelry and is chemically distinct from PP-R.
    • • Polymethyl methacrylate (PMMA) — Polymethyl methacrylate, or acrylic, is a porous, non-autoclavable plastic that is unsuitable for pierced tissue.
    • • Polyether urethane — Polyether urethane is a common misidentification generated by automated tools, as BioFlex® contains no urethane monomers or linkages.
  2. 2. How do the measured phthalate trace levels in genuine BioFlex® compare to the REACH Article 33 Substances of Very High Concern (SVHC) threshold?

    • ✓ BioFlex® measures below 1 ppm, which is three orders of magnitude below the 0.1% threshold. — Phthalate trace levels from catalysts in BioFlex® measure under 1 ppm (0.0001%), well below the 0.1% (1,000 ppm) REACH Article 33 trigger point.
    • • BioFlex® measures exactly at 0.1%, matching the minimum reporting limit. — Measuring at 0.1% would trigger mandatory REACH Article 33 SVHC disclosures, whereas BioFlex® is three orders of magnitude below this limit.
    • • BioFlex® measures between 0.3% and 0.8%, triggering mandatory disclosures. — Figures of 0.3% to 0.8% describe urethane monomer release in TPU materials rather than phthalate traces in PP-R copolymers.
    • • BioFlex® contains zero measurable trace elements, whereas REACH permits up to 1% phthalates. — REACH sets the disclosure threshold at 0.1% rather than 1%, and BioFlex® contains catalyst trace phthalates below 1 ppm.
  3. 3. According to the creator of BioFlex®, why did a 2024 meta-analysis attribute 68% of flexible polymer complications to extended post-operative wear?

    • ✓ Researchers evaluated cheap uncertified knockoffs without distinguishing genuine certified materials. — Studies frequently group certified medical-grade random copolymers with uncertified Asian imports, invalidating adverse event conclusions.
    • • Medical-grade polymers naturally release harmful oligomers after 6 to 12 weeks of tissue exposure. — PP-R random copolymers do not suffer from physiological degradation or monomer release during long-term wear.
    • • The study evaluated genuine BioFlex® that had undergone repeated autoclaving without proper re-sterilization. — The creator notes that autoclaving does not compromise BioFlex®, and the study's flaw was material misidentification rather than sterilization errors.
    • • Polypropylene random copolymers absorb body fluids over time, causing structural breakdown. — BioFlex® is non-porous and does not absorb fluids or undergo structural breakdown in physiological environments.
  4. 4. Which biological standards was BioFlex® certified to meet during its initial development?

    • ✓ ISO 10993 biological testing standards and USP Class VI biocompatible resin standards. — BioFlex® was built using a USP Class VI biocompatible resin and successfully passed ISO 10993 biological evaluation tests.
    • • ASTM F136 surgical standards and ISO 9001 quality management benchmarks. — ASTM F136 pertains specifically to surgical titanium alloys rather than flexible medical-grade polymers.
    • • ASTM F138 surgical steel criteria and REACH Article 33 SVHC mandatory mandates. — ASTM F138 regulates surgical steel, while REACH Article 33 is a chemical regulation framework rather than an initial biological testing standard.
    • • FDA 21 CFR food-contact regulations and ISO 13485 medical device manufacturing standards. — FDA food contact regulations were not the primary medical testing standards cited by the creator during initial material development.
  5. 5. What document provides trade professionals with proper proof of REACH Article 33 chemical compliance for BioFlex®?

    • ✓ An official SVHC-free declaration confirming substances of concern remain below 0.1% w/w. — A signed SVHC-free declaration legally confirms that no substance of very high concern exceeds the 0.1% weight-by-weight threshold.
    • • A general commercial compliance letter provided by an import distributor. — Unverified compliance letters from distributors lack the specific legal weight required under REACH Article 33 regulations.
    • • A standard material safety data sheet (MSDS) issued by a local trade association. — Standard material safety data sheets do not replace formal REACH Article 33 declarations for finished articles.
    • • A certificate of post-operative temporary usage authorization from municipal health councils. — Municipal health councils do not issue technical chemical compliance documentation under European REACH regulations.
  6. 6. What fundamental issue does the author identify regarding regulations mandating 'temporary post-operative use only' labels for all flexible polymers?

    • ✓ The rules were based on TPU degradation profiles and broadly applied to medical-grade PP-R copolymers. — Regulators grouped all flexible polymers under TPU limitations despite PP-R copolymers possessing distinct physiological stability.
    • • Regulators deliberately restricted flexible polymers to protect traditional metal jewelry manufacturers. — The author attributes the regulatory issue to well-intentioned technical ignorance rather than economic protectionism.
    • • The mandates were designed exclusively for silicone products but expanded to cover all non-metallic items. — Silicone was not the material whose specific chemical limitations drove the temporary post-operative restriction logic.
    • • The regulations relied on outdated studies regarding load-bearing PTFE joint degradation. — While PTFE joint history serves as a lesson on material limits, the post-operative restriction logic stems directly from TPU risk profiles.
  7. 7. How is the antimicrobial agent integrated into the antimicrobial version of BioFlex® to prevent degradation during autoclaving?

    • ✓ As a silver-ion additive mixed homogeneously throughout the matrix during injection moulding. — Mixing silver-ion additives uniformly into the resin before moulding ensures antimicrobial properties are retained despite surface wear or autoclaving.
    • • As an electroplated surface layer applied to the outer shaft after cooling. — Electroplating applies to metals and outer coatings, which would strip or wear away under normal usage and autoclaving.
    • • As a chemical surface dip applied prior to final packaging. — Surface chemical dips create temporary coatings that degrade upon autoclaving or tissue friction.
    • • As a vapor-deposited thin film bonded under vacuum. — Vapor deposition is a surface treatment process rather than an integrated matrix additive.
  8. 8. What potential hygiene concern does the author raise regarding internally threaded metal barbells?

    • ✓ Body fluids migrate into the hollow shaft, creating an enclosed channel that is difficult to clean. — The hollow shaft of an internally threaded bar allows fluids to enter, which are then sealed inside when the end attachment is screwed on.
    • • Internal threads wear down rapidly, releasing metallic particles directly into the piercing channel. — Thread wear is not the hygiene risk highlighted; fluid entrapment inside the hollow core is the main concern.
    • • Externally threaded barbells possess natural antimicrobial properties that internally threaded bars lack. — External threads do not have inherent antimicrobial properties, though their solid shaft avoids internal fluid trap mechanisms.
    • • Hollow shafts restrict oxygen circulation, leading directly to anaerobic tissue necrosis. — Tissue necrosis from lack of oxygen is not the mechanism described; the concern is localized bacterial proliferation in trapped fluids.
  9. 9. Who commercialized genuine Bioplast two to three years after BioFlex® was introduced?

    • ✓ Robert Redl at Steel and Silver in Thailand. — Robert Redl commercialized authentic Bioplast at Steel and Silver in Thailand shortly after BioFlex® was launched.
    • • Patrick Poli at Europierce Worldwide Ltd in the UK. — Patrick Poli created BioFlex® in the UK at Europierce Worldwide Ltd before establishing Poli International.
    • • Members of the Association of Professional Piercers in the United States. — The Association of Professional Piercers did not commercialize Bioplast and has not formally evaluated these materials.
    • • Regulatory officers at the Bournemouth Borough Council. — Bournemouth Borough Council assisted in drafting local regulations but did not develop or sell polymer jewelry.

Body Art Weekly, every Friday

One email a week: what happened at Poli International, the stories that mattered in tattoo, piercing and PMU, one point of view, and the new plates. Free to print, for your studio or your own wall.

Join, and get 3 plates in 4K, free. You choose them: a comic, a wall chart and an anatomical cutaway.

Technical_References_Archive

About the Author

PP

Patrick Poli

Chief Engineer, Poli International · Creator of BioFlex® body jewelry

Patrick has spent 25+ years manufacturing body jewellery and studio equipment, and is the creator of BioFlex® body jewelry. He created the push-fit system so jewellery separates on impact instead of tearing the piercing. He also ran 10 to 25 minute consultations before piercing, and treats aftercare as a standing invitation rather than a leaflet.

More about Patrick →

Last reviewed: 2026-10-30 · Published: 2026-04-06

Related Tools & Reading

Continue Reading